Youg Raj Thaker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Youg Raj Thaker has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Gerhard Grüber
Nanyang Technological University, School of Biological Sciences, Singapore, Republic of Singapore
5 shared publications- Gerhard Grüber
School of Biological Sciences Nanyang Technological University Singapore Republic of Singapore
5 shared publications Sankaranarayanan Rishikesan
School of Biological Sciences, Nanyang Technological University, Singapore, Republic of Singapore
4 shared publicationsAnastasia Bakulina
Novosibirsk State University, Novosibirsk, Russia
3 shared publicationsCornelia Hunke
Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore
3 shared publications- Shovanlal Gayen
Jadavpur University
3 shared publications
Latest Publications
- Open Access
- 6 October 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (1)
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
Inhibitory signals through the PD-1 pathway regulate T cell activation, T cell tolerance, and T cell exhaustion. Studies of PD-1 function have focused primarily on effector T cells. Far less is known about PD-1 function in regulatory T (T reg) cells. To study the role of PD-1 in T reg cells, we generated mice that selectively lack PD-1 in T reg cells. PD-1–deficient T reg cells exhibit an activated phenotype and enhanced immunosuppressive function. The in vivo significance of the potent suppressive capacity of PD-1–deficient T reg cells is illustrated by ameliorated experimental autoimmune encephalomyelitis (EAE) and protection from diabetes in nonobese diabetic (NOD) mice lacking PD-1 selectively in T reg cells. We identified reduced signaling through the PI3K–AKT pathway as a mechanism underlying the enhanced suppressive capacity of PD-1–deficient T reg cells. Our findings demonstrate that cell-intrinsic PD-1 restraint of T reg cells is a significant mechanism by which PD-1 inhibitory signals regulate T cell tolerance and autoimmunity.
- 6 October 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (1)
Open AccessPD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
Inhibitory signals through the PD-1 pathway regulate T cell activation, T cell tolerance, and T cell exhaustion. Studies of PD-1 function have focused primarily on effector T cells. Far less is known about PD-1 function in regulatory T (T reg) cells. To study the role of PD-1 in T reg cells, we generated mice that selectively lack PD-1 in T reg cells. PD-1–deficient T reg cells exhibit an activated phenotype and enhanced immunosuppressive function. The in vivo significance of the potent suppressive capacity of PD-1–deficient T reg cells is illustrated by ameliorated experimental autoimmune encephalomyelitis (EAE) and protection from diabetes in nonobese diabetic (NOD) mice lacking PD-1 selectively in T reg cells. We identified reduced signaling through the PI3K–AKT pathway as a mechanism underlying the enhanced suppressive capacity of PD-1–deficient T reg cells. Our findings demonstrate that cell-intrinsic PD-1 restraint of T reg cells is a significant mechanism by which PD-1 inhibitory signals regulate T cell tolerance and autoimmunity.
- Open Access
- 22 October 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
GTPase-activating protein Rasal1 associates with ZAP-70 of the TCR and negatively regulates T-cell tumor immunity
Immunotherapy involving checkpoint blockades of inhibitory co-receptors is effective in combating cancer. Despite this, the full range of mediators that inhibit T-cell activation and influence anti-tumor immunity is unclear. Here, we identify the GTPase-activating protein (GAP) Rasal1 as a novel TCR-ZAP-70 binding protein that negatively regulates T-cell activation and tumor immunity. Rasal1 inhibits via two pathways, the binding and inhibition of the kinase domain of ZAP-70, and GAP inhibition of the p21ras-ERK pathway. It is expressed in activated CD4 + and CD8 + T-cells, and inhibits CD4 + T-cell responses to antigenic peptides presented by dendritic cells as well as CD4 + T-cell responses to peptide antigens in vivo. Furthermore, siRNA reduction of Rasal1 expression in T-cells shrinks B16 melanoma and EL-4 lymphoma tumors, concurrent with an increase in CD8 + tumor-infiltrating T-cells expressing granzyme B and interferon γ-1. Our findings identify ZAP-70-associated Rasal1 as a new negative regulator of T-cell activation and tumor immunity.
- 22 October 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
Open AccessGTPase-activating protein Rasal1 associates with ZAP-70 of the TCR and negatively regulates T-cell tumor immunity
Immunotherapy involving checkpoint blockades of inhibitory co-receptors is effective in combating cancer. Despite this, the full range of mediators that inhibit T-cell activation and influence anti-tumor immunity is unclear. Here, we identify the GTPase-activating protein (GAP) Rasal1 as a novel TCR-ZAP-70 binding protein that negatively regulates T-cell activation and tumor immunity. Rasal1 inhibits via two pathways, the binding and inhibition of the kinase domain of ZAP-70, and GAP inhibition of the p21ras-ERK pathway. It is expressed in activated CD4 + and CD8 + T-cells, and inhibits CD4 + T-cell responses to antigenic peptides presented by dendritic cells as well as CD4 + T-cell responses to peptide antigens in vivo. Furthermore, siRNA reduction of Rasal1 expression in T-cells shrinks B16 melanoma and EL-4 lymphoma tumors, concurrent with an increase in CD8 + tumor-infiltrating T-cells expressing granzyme B and interferon γ-1. Our findings identify ZAP-70-associated Rasal1 as a new negative regulator of T-cell activation and tumor immunity.
- 1 January 2019
- Published by Elsevier
- Vol. 83, 77-106
Structural model of a2-subunit N-terminus and its binding interface for Arf-GEF CTH2: Implication for regulation of V-ATPase, CTH2 function and rational drug design
- 1 January 2019
- Published by Elsevier
- Vol. 83, 77-106
Structural model of a2-subunit N-terminus and its binding interface for Arf-GEF CTH2: Implication for regulation of V-ATPase, CTH2 function and rational drug design
- Open Access
- 1 April 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (15) , 6281-6290
Activated Cdc42-associated kinase 1 (ACK1) binds the sterile α motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines
- 1 April 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (15) , 6281-6290
Open AccessActivated Cdc42-associated kinase 1 (ACK1) binds the sterile α motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines
- Open Access
- 1 January 2015
- Published by Elsevier in Immunology Letters
- Vol. 163 (1) , 113-119
TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes
- 1 January 2015
- Published by Elsevier in Immunology Letters
- Vol. 163 (1) , 113-119
Open AccessTCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes
- Open Access
- 1 October 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (41) , 29539-29549
SLP-76 Sterile α Motif (SAM) and Individual H5 α Helix Mediate Oligomer Formation for Microclusters and T-cell Activation
- 1 October 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (41) , 29539-29549
Open AccessSLP-76 Sterile α Motif (SAM) and Individual H5 α Helix Mediate Oligomer Formation for Microclusters and T-cell Activation
- Open Access
- 18 September 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 101
Immune adaptor ADAP in T cells regulates HIV-1 transcription and cell-cell viral spread via different co-receptors
Immune cell adaptor protein ADAP (adhesion and degranulation-promoting adaptor protein) mediates aspects of T-cell adhesion and proliferation. Despite this, a connection between ADAP and infection by the HIV-1 (human immunodeficiency virus-1) has not been explored.
- 18 September 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 101
Open AccessImmune adaptor ADAP in T cells regulates HIV-1 transcription and cell-cell viral spread via different co-receptors
Immune cell adaptor protein ADAP (adhesion and degranulation-promoting adaptor protein) mediates aspects of T-cell adhesion and proliferation. Despite this, a connection between ADAP and infection by the HIV-1 (human immunodeficiency virus-1) has not been explored.
- 12 March 2011
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 43 (2) , 187-193
NMR solution structure of subunit E (fragment E1–69) of the Saccharomyces cerevisiae V1VO ATPase
The N-terminus of V-ATPase subunit E has been shown to associate with the subunits C, G and H, respectively. To understand the assembly of E with its neighboring subunits as well as its N-terminal structure, the N-terminal region, E1-69, of the Saccharomyces cerevisiae V-ATPase subunit E was expressed and purified. The solution structure of E1-69 was determined by NMR spectroscopy. The protein is 90.3 Å in length and forms an á-helix between the residues 12–68. The molecule is amphipathic with hydrophobic residues at the N-terminus, predicted to interact with subunit C. The polar epitopes of E1–69 are discussed as areas interacting with subunits G and H.
- 12 March 2011
- Published by Springer Nature in Journal of Bioenergetics and Biomembranes
- Vol. 43 (2) , 187-193
NMR solution structure of subunit E (fragment E1–69) of the Saccharomyces cerevisiae V1VO ATPase
The N-terminus of V-ATPase subunit E has been shown to associate with the subunits C, G and H, respectively. To understand the assembly of E with its neighboring subunits as well as its N-terminal structure, the N-terminal region, E1-69, of the Saccharomyces cerevisiae V-ATPase subunit E was expressed and purified. The solution structure of E1-69 was determined by NMR spectroscopy. The protein is 90.3 Å in length and forms an á-helix between the residues 12–68. The molecule is amphipathic with hydrophobic residues at the N-terminus, predicted to interact with subunit C. The polar epitopes of E1–69 are discussed as areas interacting with subunits G and H.
- 31 January 2011
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1808 (1) , 360-368
Solution structure of subunit F (Vma7p) of the eukaryotic V1VO ATPase from Saccharomyces cerevisiae derived from SAXS and NMR spectroscopy
- 31 January 2011
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1808 (1) , 360-368
Solution structure of subunit F (Vma7p) of the eukaryotic V1VO ATPase from Saccharomyces cerevisiae derived from SAXS and NMR spectroscopy